Non-Small Cell Lung Cancer; A Disease That Affects Inside And Outside Of Lungs
![]() |
Non-Small Cell Lung Cancer |
About
85 percent of lung cancers are Non-Small
Cell Lung Cancer (NSCLC), also called large cell carcinoma. This type of
cancer starts in the cells that line the inside and outside of the lungs.
Doctors determine which type of NSCLC patients have based on how their cancer
looks under a microscope and the kind of cells it starts in. Surgical removal
of the cancer is the most common treatment for early stage NSCLC.
There
are many ways to treat Non-Small
Cell Lung Cancer. Some methods use drugs to kill or slow down
the growth of the cancer. Other methods involve using the immune system to
fight the cancer. Drugs that target a certain cancer cell or a specific
molecular change in the cancer are called targeted therapy. These drugs are
matched to each tumor after genetic tests. The drugs are taken in pill form or
by mouth.
Other
types of cancers may be treated with chemotherapy or radiation, which both kill
cancer cells. These treatments can help reduce symptoms and improve the ability
to breathe. Chemotherapy is the most common treatment for lung cancer and can
be very effective. Some people who have non-small cell lung cancer need more
than one type of chemotherapy to get the best results. Chemotherapy is a drug
that kills cancer cells. It can be given by injection into the vein or by
taking a pill that patient can swallow.
Radiation
is another treatment option for Non-Small
Cell Lung Cancer. It can help shrink the tumor and make it easier to remove
with surgery or to cut out. It can also help prevent the cancer from coming
back.
Immunotherapy
is another treatment option for some people with advanced lung cancer that has
spread to other parts of the body. This treatment uses medications called
checkpoint inhibitors to boost the immune system so it can attack cancer cells.
Other
types of medicines can be used to treat some people with non-small cell lung
cancer that has spread to other parts of their bodies or that has recurred
(come back). These include monoclonal antibodies and tyrosine kinase
inhibitors.
The
goal of treatment for most people with Non-Small
Cell Lung Cancer is to shrink the tumor and improve the health. The patient
may need to have regular check-ups and follow-up tests to see how well the
treatment is working. In May 2022, Chugai received regulatory approval from the
Ministry of Health, Labor and Welfare of Japan, for its Tecentriq designed to
treat NSCLC.
Comments
Post a Comment